Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma von Chapuy, Bjoern, McKeown, Michael R., Lin, Charles Y., Monti, Stefano, Roemer, Margaretha G.M., Qi, Jun, Rahl, Peter B., Sun, Heather H., Yeda, Kelly T., Doench, John G., Reichert, Elaine, Kung, Andrew L., Rodig, Scott J., Young, Richard A., Shipp, Margaret A., Bradner, James E.

Volltext

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma von Chen, Robert, Zinzani, Pier Luigi, Fanale, Michelle A, Armand, Philippe, Johnson, Nathalie A, Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P, Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A, Zhang, Yinghua, Ricart, Alejandro D, Balakumaran, Arun, Moskowitz, Craig H

Volltext

Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors von Croci, Diego O., Cerliani, Juan P., Dalotto-Moreno, Tomas, Méndez-Huergo, Santiago P., Mascanfroni, Ivan D., Dergan-Dylon, Sebastián, Toscano, Marta A., Caramelo, Julio J., García-Vallejo, Juan J., Ouyang, Jing, Mesri, Enrique A., Junttila, Melissa R., Bais, Carlos, Shipp, Margaret A., Salatino, Mariana, Rabinovich, Gabriel A.

Volltext

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II... von Armand, Philippe, Engert, Andreas, Younes, Anas, Fanale, Michelle, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John M, Collins, Graham P, Ramchandren, Radhakrishnan, Cohen, Jonathon B, De Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J, Trneny, Marek, Shipp, Margaret A, Kato, Kazunobu, Sumbul, Anne, Farsaci, Benedetto, Ansell, Stephen M

Volltext

The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo von Karreth, Florian A., Reschke, Markus, Ruocco, Anna, Ng, Christopher, Chapuy, Bjoern, Léopold, Valentine, Sjoberg, Marcela, Keane, Thomas M., Verma, Akanksha, Ala, Ugo, Tay, Yvonne, Wu, David, Seitzer, Nina, Velasco-Herrera, Martin Del Castillo, Bothmer, Anne, Fung, Jacqueline, Langellotto, Fernanda, Rodig, Scott J., Elemento, Olivier, Shipp, Margaret A., Adams, David J., Chiarle, Roberto, Pandolfi, Pier Paolo

Volltext

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 von Chen, Robert, Zinzani, Pier Luigi, Lee, Hun Ju, Armand, Philippe, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Lin, Jianxin, Kim, Eunhee, Nahar, Akash, Balakumaran, Arun, Moskowitz, Craig H.

Volltext

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma von Liu, W. Robert, Shipp, Margaret A.

Volltext

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study von Ansell, Stephen M, Minnema, Monique C, Johnson, Peter, Timmerman, John M, Armand, Philippe, Shipp, Margaret A, Rodig, Scott J, Ligon, Azra H, Roemer, Margaretha G M, Reddy, Nishitha, Cohen, Jonathon B, Assouline, Sarit, Poon, Michelle, Sharma, Manish, Kato, Kazunobu, Samakoglu, Selda, Sumbul, Anne, Grigg, Andrew

Volltext

Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma von Caro, Pilar, Kishan, Amar U., Norberg, Erik, Stanley, Illana A., Chapuy, Bjoern, Ficarro, Scott B., Polak, Klaudia, Tondera, Daniel, Gounarides, John, Yin, Hong, Zhou, Feng, Green, Michael R., Chen, Linfeng, Monti, Stefano, Marto, Jarrod A., Shipp, Margaret A., Danial, Nika N.

Volltext

NLRC5/MHC class I transactivator is a target for immune evasion in cancer von Yoshihama, Sayuri, Roszik, Jason, Downs, Isaac, Meissner, Torsten B., Vijayan, Saptha, Chapuy, Bjoern, Sidiq, Tabasum, Shipp, Margaret A., Lizee, Gregory A., Kobayashi, Koichi S.

Volltext

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma von Nayak, Lakshmi, Iwamoto, Fabio M., LaCasce, Ann, Mukundan, Srinivasan, Roemer, Margaretha G.M., Chapuy, Bjoern, Armand, Philippe, Rodig, Scott J., Shipp, Margaret A.

Volltext

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome von Roemer, Margaretha G M, Advani, Ranjana H, Ligon, Azra H, Natkunam, Yasodha, Redd, Robert A, Homer, Heather, Connelly, Courtney F, Sun, Heather H, Daadi, Sarah E, Freeman, Gordon J, Armand, Philippe, Chapuy, Bjoern, de Jong, Daphne, Hoppe, Richard T, Neuberg, Donna S, Rodig, Scott J, Shipp, Margaret A

Volltext

Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma von Carey, Christopher D., Gusenleitner, Daniel, Lipschitz, Mikel, Roemer, Margaretha G.M., Stack, Edward C., Gjini, Evisa, Hu, Xihao, Redd, Robert, Freeman, Gordon J., Neuberg, Donna, Hodi, F. Stephen, Liu, Xiaole Shirley, Shipp, Margaret A., Rodig, Scott J.

Volltext

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy von GREEN, Michael R, RODIG, Scott, JUSZCZYNSKI, Przemyslaw, JING OUYANG, SINHA, Papiya, O'DONNELL, Evan, NEUBERG, Donna, SHIPP, Margaret A

Volltext

Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas von Kluk, Michael J, Chapuy, Bjoern, Sinha, Papiya, Roy, Alyssa, Dal Cin, Paola, Neuberg, Donna S, Monti, Stefano, Pinkus, Geraldine S, Shipp, Margaret A, Rodig, Scott J

Volltext

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma von Zinzani, Pier Luigi, Ribrag, Vincent, Moskowitz, Craig H., Michot, Jean-Marie, Kuruvilla, John, Balakumaran, Arun, Zhang, Yayan, Chlosta, Sabine, Shipp, Margaret A., Armand, Philippe

Volltext

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study von Ramchandren, Radhakrishnan, Domingo-Domènech, Eva, Rueda, Antonio, Trněný, Marek, Feldman, Tatyana A, Lee, Hun Ju, Provencio, Mariano, Sillaber, Christian, Cohen, Jonathon B, Savage, Kerry J, Willenbacher, Wolfgang, Ligon, Azra H, Ouyang, Jing, Redd, Robert, Rodig, Scott J, Shipp, Margaret A, Sacchi, Mariana, Sumbul, Anne, Armand, Philippe, Ansell, Stephen M

Volltext

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies von CHEN, Benjamin J, CHAPUY, Bjoern, RODIG, Scott J, OUYANG, Jing, SUN, Heather H, ROEMER, Margaretha G. M, XU, Mina L, HONGBO YU, FLETCHER, Christopher D. M, FREEMAN, Gordon J, SHIPP, Margaret A

Volltext

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure von Armand, Philippe, Shipp, Margaret A, Ribrag, Vincent, Michot, Jean-Marie, Zinzani, Pier Luigi, Kuruvilla, John, Snyder, Ellen S, Ricart, Alejandro D, Balakumaran, Arun, Rose, Shelonitda, Moskowitz, Craig H

Volltext

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary med... von Green, Michael R., Monti, Stefano, Rodig, Scott J., Juszczynski, Przemyslaw, Currie, Treeve, O'Donnell, Evan, Chapuy, Bjoern, Takeyama, Kunihiko, Neuberg, Donna, Golub, Todd R., Kutok, Jeffery L., Shipp, Margaret A.

Volltext